David Colleran's Net Worth

$11.5 Million

Estimate Recalculated Sep 12, 2024 08:10PM EST

Who is David Colleran

David Colleran has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include INSULET CORP, and Anika Therapeutics, Inc..

SEC CIK

David Colleran's CIK is 0001646558

Past Insider Trading and Trends

2019 was David Colleran's most active year for acquiring shares with 7 total transactions. David Colleran's most active month to acquire stocks was the month of February. 2019 was David Colleran's most active year for disposing of shares, totalling 14 transactions. David Colleran's most active month to dispose stocks was the month of February. 2019 saw David Colleran paying a total of $1,315,812.92 for 40,030 shares, this is the most they've acquired in one year. In 2019 David Colleran cashed out on 84,072 shares for a total of $3,975,511.21, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSULET CORP

SVP, Secretary and GC
Updated Apr 04, 2019
Form 4
-17.81%
-7.39K
$62.94
-$472.61K
Apr 04, 2019
34.13K
Sale
ScheduledApr 02
Form 4
-26.46%
-20.98K
$65.10
-$1.24M
Mar 05, 2019
58.29K
Sale
Mar 01
Form 4
-10.97%
-3.75K
$87.60
-$328.32K
Feb 26, 2019
30.43K
Tax
Feb 22 - Feb 24
Form 4
-0.77%
-264.00
$84.83
-$22.40K
Feb 19, 2019
34.18K
Tax
Feb 14
Form 4
-14.25%
-6.83K
$54.99
-$351.68K
Feb 06, 2019
41.13K
Sale
ScheduledFeb 05
Form 4
-9.14%
-4.83K
$54.63
-$244.87K
Feb 01, 2019
47.96K
Sale
ScheduledJan 31
Form 4
-8.15%
-6.11K
$61.01
-$237.18K
Nov 15, 2018
68.88K
Sale
ScheduledNov 14
Form 4
-8.60%
-3.21K
$85.70
-$274.67K
Jul 03, 2018
34.04K
Tax
Jun 29
Form 4
-11.77%
-4.96K
$86.24
-$427.41K
May 16, 2018
37.14K
Sale
ScheduledMay 15
Form 4
-5.46%
-2.43K
$75.55
-$183.59K
Feb 27, 2018
42.10K
Tax
Feb 24
Form 4
-1.04%
-470.00
$80.46
-$37.82K
Feb 26, 2018
44.53K
Tax
Feb 22
Form 4
71.31%
21.64K
Feb 15, 2018
51.99K
Grant
Feb 13 - Feb 14
Form 4
60.11%
15.70K
Feb 24, 2017
41.81K
Grant
Feb 22
Form 4
-8.25%
-2.35K
$29.71
-$69.73K
Jun 30, 2016
26.12K
Tax
Jun 29
Form 4
117.87%
25.49K
Feb 26, 2016
47.12K
Grant
Feb 24
Form 3
Jul 20, 2015
21.63K
Showing 16 results

Anika Therapeutics, Inc.

EVP, General Counsel, Corp Sec
Updated Mar 19, 2024
Form 4
66.22K
Mar 19, 2024
66.22K
Grant
Mar 15
Form 4
-8.73%
-4.94K
$25.59
-$126.31K
Mar 12, 2024
51.59K
Options
Mar 11
Form 4
-5.94%
-2.25K
$26.10
-$58.72K
Mar 14, 2023
35.61K
Options
Mar 10
Form 4
260.23%
51.10K
$26.91
-$29.09K
Mar 10, 2023
70.74K
Options
Mar 09
Form 4
-5.64%
-734.00
$31.59
-$23.19K
Mar 07, 2023
12.27K
Options
Mar 04
Form 4
17.93%
1.50K
$21.37
$32.06K
May 12, 2022
9.87K
Purchase
May 11
Form 4
21.84%
1.50K
$26.65
$39.98K
Mar 16, 2022
8.37K
Purchase
Mar 14
Form 4
58.85K
Mar 15, 2022
58.85K
Grant
Mar 11
Form 4
-7.06%
-1.08K
$26.22
-$28.34K
Mar 11, 2022
14.23K
Options
Mar 09
Form 4
-9.79%
-734.00
$31.06
-$22.80K
Mar 07, 2022
6.77K
Options
Mar 04
Form 4
38.73K
Mar 11, 2021
38.73K
Grant
Mar 09
Form 4
Mar 08, 2021
7.50K
Options
Mar 04
Form 4
42.50K
Mar 06, 2020
42.50K
Grant
Mar 04
Form 3
Mar 06, 2020
Showing 14 results